Anti-Spike (RBD) Antibody


1 mg


BioServUK offers a series of different monoclonal antibodies for the detection of the SARS-CoV-2 Spike. All antibodies come from hybridoma cell lines that were generated by immunization with the recombinant full-length Spike protein (S) or the receptor-binding domain (RBD).

This antibody has been validated by ELISA and is specifically directed against an epitope that is located on the RBD. It is produced exclusively under serum‐free conditions form hybridoma and purified through one-step purification with Protein-A affinity chromatography.

Host: Mouse
Clonality: Monoclonal
Isotype: IgG
Subclass: mIgG1k
Formulation: Liquid, PBS, pH 7.4, 0.2 µm sterile filtered
Concentration: ≥ 0.5 mg/ mL
Purity: ≥ 90% (via analytical CGE under reducing conditions)
Conjugate: Unconjugated
Specificity: S (tested for: Wuhan and B.1.1.7)
RBD (tested for: Wuhan, B.1.1.7, B., B.1.1.7 E484K and